Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Candel Therapeutics Q4 Earnings

Candel Therapeutics (NASDAQ:CADL) reported its Q4 earnings results on Thursday, March 28, 2024 at 08:05 AM. Here’s what…
byBenzinga Insights
March 28, 2024
1 minute read
Total
0
Shares
0
0
0
0
0
0

Candel Therapeutics (NASDAQ:CADL) reported its Q4 earnings results on Thursday, March 28, 2024 at 08:05 AM.

Here’s what investors need to know about the announcement.

Earnings

Candel Therapeutics missed estimated earnings by -138.0%, reporting an EPS of $-0.38 versus an estimate of $-0.16.

Revenue was down $31 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.1 which was followed by a 4.0% increase in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Candel Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Snap Stock Falters As Growth Slows To Record Low

By MarketBeat
July 22, 10:59 AM
- Revenue came in at $1.11 billion missing estimates of $1.14 billion by analysts. Revenue grew by 13% y-o-y, the slowest on record. - Earnings per share came in at -26 cents versus -10 cents during the same quarter in 2021. - Adjusted EBITDA came in at $7.19 million, meanwhile unadjusted losses came in at $1.24 million.

SNAP

Read More

Ryder System: Q3 Earnings Insights

By Benzinga Insights
October 26, 8:03 AM
Ryder System (NYSE:R) reported its Q3 earnings results on Wednesday, October 26, 2022 at 07:55 AM. Here's what investors need to know about the announcement. Earnings Ryder System beat estimated earnings by 21.92%, reporting an EPS of $4.45 versus an estimate of $3.65.

R